As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

After the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Venus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...

Zydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...

In a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

India has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja Hospital, led by Dr. ...

Shares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...

Amrita Hospital's Department of Hematology, Medical Oncology and BMT helps patients treat blood disorders, benign diseases, as well as bloo...

This was stated by the Drugs Controller General of India in a letter to to HCG Bangalore Institute of Oncology Speciality Centre. The permi...

As part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentatio...

Philips Healthcare has entered into an exclusive agreement with Belgium-headquartered IBA to provide proton therapy solutions in India.

Health ministry will hold an inter-ministerial meeting to ensure that the existing FDI in the pharma sector is not at variance with the pub...

Tata Memorial Hospital’s doctors are working on alternatives that could cost less than Rs 1,000 a month.

Corporate healthcare pioneer Apollo Hospitals has invested Rs 75 crore on setting up a speciality cancer hospital in the heart of the city.

Ranbaxy on Wednesday announced a strategic tie-up with Hyderabad-based Zenotech Laboratories for marketing the latter’s oncology products i...